Causal claim

Sgk1 Inhibitor Treatment Depressive Episode

Sgk1 Inhibitor Treatment decreases Depressive Episode.

They pull in opposite directions: more cause, less effect. The map scores it at 25% confidence, weighed from 1 article.

How it works

Drugs that block SGK1 could offer a new antidepressant mechanism, especially for SSRI-resistant patients

The evidence

Where it sits

What feeds it

Nothing upstream on the map yet.

See it on the live map →